Skip to content
Business Times – Lifestyle
Author:
BriaCell Therapeutics Corp.
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
May 6, 2026
BriaCell Announces Six Clinical Data Presentations at ASCO 2026
April 29, 2026
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
April 28, 2026
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting
April 28, 2026
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
March 31, 2026
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference
March 18, 2026
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
March 10, 2026
←
Previous Page
1
2